Tudor Investment Corp’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Buy |
31,714
+122
| +0.4% | +$5.76K | ﹤0.01% | 984 |
|
|
2025
Q1 | $1.23M | Buy |
+31,592
| New | +$1.23M | ﹤0.01% | 960 |
|
|
2024
Q4 | – | Sell |
-31,840
| Closed | -$1.61M | – | 1904 |
|
|
2024
Q3 | $1.61M | Buy |
31,840
+4,667
| +17% | +$235K | 0.01% | 843 |
|
|
2024
Q2 | $1.19M | Sell |
27,173
-4,238
| -13% | -$186K | 0.01% | 914 |
|
|
2024
Q1 | $1.58M | Buy |
31,411
+1,257
| +4% | +$63.1K | 0.01% | 752 |
|
|
2023
Q4 | $1.82M | Buy |
30,154
+13,059
| +76% | +$789K | 0.01% | 742 |
|
|
2023
Q3 | $974K | Buy |
17,095
+3,546
| +26% | +$202K | 0.01% | 918 |
|
|
2023
Q2 | $691K | Buy |
+13,549
| New | +$691K | 0.01% | 1026 |
|